Sugar Editorial Picks
May 27, 2009 -
I love the industrial, retro look of this Modern Dose Fisherman Light ($235). Its silver-toned steel surface provides a great neutral palette that one could decorate around, or simply add to an already-established room's decor. And while it's rather reasonably priced, if I want to decorate with multiples of these (I can see three of them hanging in my kitchen), they do add up.
- 7 Comments
Sep 25, 2008 -
Aphrodite had the mythological ability make any man fall in love with her, but I think she works her ways with the ladies, too. The Modern Dose Aphrodite Shelf ($145) certainly has my heart all aflutter, giving the neoclassical a modern edge with acrylic in the shape of an ancient Grecian bust. And you know me, I always need another place to store all of my shelter magazines!
- 4 Comments
Other Search Results
May 06, 2008 -
If you're still feeling the zebra trend, but have yet to pick up on it, perhaps the Modern Dose Cowhide Zebra Rug ($475, from $575) is for you. It's certainly stylish, and its stripes will add a nice graphic quality to your home. But, this rug is more of a statement than a comfort piece; if you're going for a cozy lounge look, I'd try a Flokati or a shag rug instead.
- 7 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Prognosis
- Risk Factors
- Symptoms
- Diagnosis
- Treatment
- Quick-Relief Medications...
- Long-Term Relief Medication...
- Other Treatments
- Managing Asthma
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Warning
In 2007, the FDA requested the manufacturers of omalizumab (Xolair) to include a “boxed warning” emphasizing that this drug may cause a severe and life-threatening allergic reaction (anaphylaxis). Health care providers need to carefully observe patients for 2 hours after they receive an omalizumab injection. However, because an allergic reaction can occur up to 24 hours after the injection, patients need to know the signs and symptoms of anaphylaxis and how to self-administer emergency treatment.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Oral Contraception
- Implant Contraception
- Injected Contraception
- Intrauterine Devices (IUDs)...
- Spermicidal and Barrier Con...
- Natural Family Planning Met...
- Emergency Contraception
- Female Sterilization
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
First "No-Period" Birth Control Pill Approved
In May 2007, the Food and Drug Administration approved Lybrel, the first birth control pill that completely eliminates monthly menstrual periods. Lybrel contains low doses of the estrogen estradiol and the progestin levonorgestrol. The active pills are taken 365 days a year with no inactive pill breaks.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Causes
- Prognosis
- Risk Factors
- Diagnosis
- Treatment
- Quick-Relief Medications...
- Long-Term Relief Medication...
- Other Treatments
- Managing Asthma
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Warning
In 2007, the FDA requested the manufacturers of omalizumab (Xolair) to include a “boxed warning” emphasizing that this drug may cause a severe and life-threatening allergic reaction (anaphylaxis). Omalizumab is approved for patients who have moderate-to-severe asthma related to allergies and whose symptoms are not controlled by inhaled corticosteroids. It is given by injection in a doctor’s office every 2 - 4 weeks.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Diagnosis
- Complications
- Risk Factors
- Prevention
- Treatment
- Medications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Vaccine News:
- On September 28, 2007, the U.S. Food and Drug Administration (FDA) approved a new brand of inactivated influenza ("flu") vaccine, Alfuria, for adults aged 18 years or older. This vaccine is given by injection.
- On September 19, 2007, the FDA approved the use of the live flu vaccine (FluMist) in healthy children as young as 2 years of age.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Prognosis
- Diagnosis
- Treatment
- Other Treatments
- Decongestants
- Antihistamines
- Corticosteroids
- Immunotherapy
- Prevention
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
Ciclesonide (Omanaris), a corticosteroid nasal spray, has been approved for treatment of seasonal and perennial allergic rhinitis (hay fever) in adults and children age 12 years and older.
FDA Drug Warnings
- The antihistamine promethazine (Phenergan) should not be given to children younger than age 2 because it may cause serious breathing problems.
- Omalizumab (Xolair) may cause a life-threatening allergic reaction (anaphylaxis). This drug is used to treat allergy-related asthma, but is also being investigated as an allergy treatment.
Cough and Cold Medicines for Children
In 2007, the FDA began reviewing the safety and effectiveness of cough and cold medicines for children.
- 0 Comments
Jun 12, 2009 -
Rome wasn't built in a day, and neither was a decorator. So, I'm continuing on with my seven steps to becoming your own decorator today with some more tips for you. The next step, which you should never lose sight of, is to find your own design style.If you tend to describe or think of your design style as "traditional" or "modern," think again.
- 4 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- The Autoimmune Disease Proc...
- Symptoms
- Causes
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Drug Treatment
- Other Treatments
- Treating the Complications...
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Gender and Multiple Sclerosis (MS)
MS is increasingly affecting women, according to research presented at the 2007 annual conference of the American Academy of Neurology. Researchers found that in the 1940s, women were twice as likely as men to be diagnosed with MS. By 2000, women were about four times more likely than men to develop MS.
- 1 Comment